Compile Data Set for Download or QSAR
Report error Found 83 Enz. Inhib. hit(s) with all data for entry = 2334
LigandPNGBDBM361913(N-[(1S)-1-{[(cis)-2,6- dimethylmorpholin-4- yl]car...)
Affinity DataIC50: 2.80nMAssay Description:Compounds are serially diluted (3-fold in 100% DMSO) across a 384-well polypropylene source plated from column 3 to column 12 and column 13 to column...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/27/2019
Entry Details
US Patent

LigandPNGBDBM361958(N-[(1S,2R)-1-{[(cis)-2,6- dimethylmorpholin-4- yl]...)
Affinity DataIC50: 3.70nMAssay Description:Compounds are serially diluted (3-fold in 100% DMSO) across a 384-well polypropylene source plated from column 3 to column 12 and column 13 to column...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/27/2019
Entry Details
US Patent

LigandPNGBDBM361902((R and S)-N-(1-{[(cis)-2,6- dimethylmorpholin-4- y...)
Affinity DataIC50: 4nMAssay Description:Compounds are serially diluted (3-fold in 100% DMSO) across a 384-well polypropylene source plated from column 3 to column 12 and column 13 to column...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/27/2019
Entry Details
US Patent

LigandPNGBDBM361946(N-{(1S)-1-cyclopropyl-2-[(cis)- 2,6-dimethylmorpho...)
Affinity DataIC50: 4.10nMAssay Description:Compounds are serially diluted (3-fold in 100% DMSO) across a 384-well polypropylene source plated from column 3 to column 12 and column 13 to column...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/27/2019
Entry Details
US Patent

LigandPNGBDBM361955(N-[(1S)-1-{[(cis)-2,6- dimethylmorpholin-4- yl]car...)
Affinity DataIC50: 4.10nMAssay Description:Compounds are serially diluted (3-fold in 100% DMSO) across a 384-well polypropylene source plated from column 3 to column 12 and column 13 to column...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/27/2019
Entry Details
US Patent

LigandPNGBDBM361976(N-[(1S)-1-{[cis-4,4-difluoro- 3,5-dimethylpiperidi...)
Affinity DataIC50: 4.80nMAssay Description:Compounds are serially diluted (3-fold in 100% DMSO) across a 384-well polypropylene source plated from column 3 to column 12 and column 13 to column...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/27/2019
Entry Details
US Patent

LigandPNGBDBM361904((R or S)-8-(1-ethyl-5-methyl-1H- pyrazol-4-yl)-9-m...)
Affinity DataIC50: 5.20nMAssay Description:Compounds are serially diluted (3-fold in 100% DMSO) across a 384-well polypropylene source plated from column 3 to column 12 and column 13 to column...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/27/2019
Entry Details
US Patent

LigandPNGBDBM361972(N-{(R or S)-1-cyclopropyl-2- [(cis)-2,6-dimethylmo...)
Affinity DataIC50: 5.20nMAssay Description:Compounds are serially diluted (3-fold in 100% DMSO) across a 384-well polypropylene source plated from column 3 to column 12 and column 13 to column...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/27/2019
Entry Details
US Patent

LigandPNGBDBM361948(N-[(1S)-1-{[(cis)-2,6- dimethylmorpholin-4- yl]car...)
Affinity DataIC50: 5.30nMAssay Description:Compounds are serially diluted (3-fold in 100% DMSO) across a 384-well polypropylene source plated from column 3 to column 12 and column 13 to column...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/27/2019
Entry Details
US Patent

LigandPNGBDBM361975(9-ethyl-8-(2-methylpyrimidin- 5-yl)-N-[(1S)-1-{[ci...)
Affinity DataIC50: 5.5nMAssay Description:Compounds are serially diluted (3-fold in 100% DMSO) across a 384-well polypropylene source plated from column 3 to column 12 and column 13 to column...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/27/2019
Entry Details
US Patent

LigandPNGBDBM361912(N-[(1S)-1-{[(cis)-2,6- dimethylmorpholin-4- yl]car...)
Affinity DataIC50: 6.10nMAssay Description:Compounds are serially diluted (3-fold in 100% DMSO) across a 384-well polypropylene source plated from column 3 to column 12 and column 13 to column...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/27/2019
Entry Details
US Patent

LigandPNGBDBM361977((S or R)-4-[(2S)-2-{[9-ethyl-8- (2-methylpyrimidin...)
Affinity DataIC50: 6.10nMAssay Description:Compounds are serially diluted (3-fold in 100% DMSO) across a 384-well polypropylene source plated from column 3 to column 12 and column 13 to column...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/27/2019
Entry Details
US Patent

LigandPNGBDBM361970(N-[(1S)-1-{[(cis)-2,6- dimethylmorpholin-4- yl]car...)
Affinity DataIC50: 6.20nMAssay Description:Compounds are serially diluted (3-fold in 100% DMSO) across a 384-well polypropylene source plated from column 3 to column 12 and column 13 to column...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/27/2019
Entry Details
US Patent

LigandPNGBDBM361906((R or S)-9-ethyl-8-(2- methylpyrimidin-5-yl)-N-[1-...)
Affinity DataIC50: 6.5nMAssay Description:Compounds are serially diluted (3-fold in 100% DMSO) across a 384-well polypropylene source plated from column 3 to column 12 and column 13 to column...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/27/2019
Entry Details
US Patent

LigandPNGBDBM361920(N-{(1S)-1-[((3a(R and S), 6a(R and S)-1,1-dioxidoh...)
Affinity DataIC50: 7nMAssay Description:Compounds are serially diluted (3-fold in 100% DMSO) across a 384-well polypropylene source plated from column 3 to column 12 and column 13 to column...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/27/2019
Entry Details
US Patent

LigandPNGBDBM361971(N-[(1S,2R)-1-{[(cis)-2,6- dimethylmorpholin-4- yl]...)
Affinity DataIC50: 8.60nMAssay Description:Compounds are serially diluted (3-fold in 100% DMSO) across a 384-well polypropylene source plated from column 3 to column 12 and column 13 to column...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/27/2019
Entry Details
US Patent

LigandPNGBDBM361956((3S)-4-[(cis)-2,6- dimethylmorpholin-4-yl]-3-{[9- ...)
Affinity DataIC50: 8.70nMAssay Description:Compounds are serially diluted (3-fold in 100% DMSO) across a 384-well polypropylene source plated from column 3 to column 12 and column 13 to column...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/27/2019
Entry Details
US Patent

LigandPNGBDBM361903((R and S)-N-{1-[(4,4- difluoropiperidin-1- yl)carb...)
Affinity DataIC50: 9nMAssay Description:Compounds are serially diluted (3-fold in 100% DMSO) across a 384-well polypropylene source plated from column 3 to column 12 and column 13 to column...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/27/2019
Entry Details
US Patent

LigandPNGBDBM361942(N-[(1S)-1-{[(trans)-2,6- dimethylmorpholin-4- yl]c...)
Affinity DataIC50: 9.10nMAssay Description:Compounds are serially diluted (3-fold in 100% DMSO) across a 384-well polypropylene source plated from column 3 to column 12 and column 13 to column...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/27/2019
Entry Details
US Patent

LigandPNGBDBM361929(9-ethyl-N-{(1S)-1-[((R and S)-3- methylpiperidin-1...)
Affinity DataIC50: 9.30nMAssay Description:Compounds are serially diluted (3-fold in 100% DMSO) across a 384-well polypropylene source plated from column 3 to column 12 and column 13 to column...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/27/2019
Entry Details
US Patent

LigandPNGBDBM361939(N-{(1S)-1-[(2,2- dimethylmorpholin-4- yl)carbonyl]...)
Affinity DataIC50: 9.80nMAssay Description:Compounds are serially diluted (3-fold in 100% DMSO) across a 384-well polypropylene source plated from column 3 to column 12 and column 13 to column...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/27/2019
Entry Details
US Patent

LigandPNGBDBM361944(9-ethyl-N-[(1S)-1-(S and R)- (hexahydropyrrolo[1,2...)
Affinity DataIC50: 10nMAssay Description:Compounds are serially diluted (3-fold in 100% DMSO) across a 384-well polypropylene source plated from column 3 to column 12 and column 13 to column...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/27/2019
Entry Details
US Patent

LigandPNGBDBM361918(N-{(1S)-1-[(3,3- difluoropiperidin-1- yl)carbonyl]...)
Affinity DataIC50: 11nMAssay Description:Compounds are serially diluted (3-fold in 100% DMSO) across a 384-well polypropylene source plated from column 3 to column 12 and column 13 to column...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/27/2019
Entry Details
US Patent

LigandPNGBDBM361935(9-ethyl-8-(2-methylpyrimidin-5- yl)-N-[(1S)-1-(4-o...)
Affinity DataIC50: 11nMAssay Description:Compounds are serially diluted (3-fold in 100% DMSO) across a 384-well polypropylene source plated from column 3 to column 12 and column 13 to column...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/27/2019
Entry Details
US Patent

LigandPNGBDBM361933(9-ethyl-8-(2-methylpyrimidin-5- yl)-N-[(1S)-1-(8-o...)
Affinity DataIC50: 11nMAssay Description:Compounds are serially diluted (3-fold in 100% DMSO) across a 384-well polypropylene source plated from column 3 to column 12 and column 13 to column...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/27/2019
Entry Details
US Patent

LigandPNGBDBM361945(N-{(1S)-2-[(cis)-2,6- dimethylmorpholin-4-yl]-1- m...)
Affinity DataIC50: 12nMAssay Description:Compounds are serially diluted (3-fold in 100% DMSO) across a 384-well polypropylene source plated from column 3 to column 12 and column 13 to column...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/27/2019
Entry Details
US Patent

LigandPNGBDBM361953((2S)-3-[(cis)-2,6- dimethylmorpholin-4-yl]-2-{[9- ...)
Affinity DataIC50: 12nMAssay Description:Compounds are serially diluted (3-fold in 100% DMSO) across a 384-well polypropylene source plated from column 3 to column 12 and column 13 to column...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/27/2019
Entry Details
US Patent

LigandPNGBDBM361940(N-{(1S)-1-[(3,3- dimethylmorpholin-4- yl)carbonyl]...)
Affinity DataIC50: 12nMAssay Description:Compounds are serially diluted (3-fold in 100% DMSO) across a 384-well polypropylene source plated from column 3 to column 12 and column 13 to column...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/27/2019
Entry Details
US Patent

LigandPNGBDBM361926(9-ethyl-8-(2-methylpyrimidin-5- yl)-N-{(1S)-1-[(ci...)
Affinity DataIC50: 14nMAssay Description:Compounds are serially diluted (3-fold in 100% DMSO) across a 384-well polypropylene source plated from column 3 to column 12 and column 13 to column...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/27/2019
Entry Details
US Patent

LigandPNGBDBM361927(N-[(1S)-1-(2-azaspiro[3.4]oct-2- ylcarbonyl)propyl...)
Affinity DataIC50: 14nMAssay Description:Compounds are serially diluted (3-fold in 100% DMSO) across a 384-well polypropylene source plated from column 3 to column 12 and column 13 to column...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/27/2019
Entry Details
US Patent

LigandPNGBDBM361907(N-[(1R)-1-benzyl-2-morpholin-4- yl-2-oxoethyl]-8-(...)
Affinity DataIC50: 15nMAssay Description:Compounds are serially diluted (3-fold in 100% DMSO) across a 384-well polypropylene source plated from column 3 to column 12 and column 13 to column...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/27/2019
Entry Details
US Patent

LigandPNGBDBM361928(N-{(1S)-1-[((R and S)-2- cyclopropylpyrrolidin-1- ...)
Affinity DataIC50: 17nMAssay Description:Compounds are serially diluted (3-fold in 100% DMSO) across a 384-well polypropylene source plated from column 3 to column 12 and column 13 to column...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/27/2019
Entry Details
US Patent

LigandPNGBDBM361969(N-[(1S)-1-{[(cis)-2,6- dimethylmorpholin-4- yl]car...)
Affinity DataIC50: 17nMAssay Description:Compounds are serially diluted (3-fold in 100% DMSO) across a 384-well polypropylene source plated from column 3 to column 12 and column 13 to column...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/27/2019
Entry Details
US Patent

LigandPNGBDBM361979(4-[(2S)-2-{[9-ethyl-8-(2- methylpyrimidin-5-yl)-9H...)
Affinity DataIC50: 19nMAssay Description:Compounds are serially diluted (3-fold in 100% DMSO) across a 384-well polypropylene source plated from column 3 to column 12 and column 13 to column...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/27/2019
Entry Details
US Patent

LigandPNGBDBM361936(N-{(1S)-1-[((S and R)-3- cyclopropylmorpholin-4- y...)
Affinity DataIC50: 19nMAssay Description:Compounds are serially diluted (3-fold in 100% DMSO) across a 384-well polypropylene source plated from column 3 to column 12 and column 13 to column...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/27/2019
Entry Details
US Patent

LigandPNGBDBM361961(N-{(2R)-3-[(cis)-2,6- dimethylmorpholin-4-yl]-2- m...)
Affinity DataIC50: 20nMAssay Description:Compounds are serially diluted (3-fold in 100% DMSO) across a 384-well polypropylene source plated from column 3 to column 12 and column 13 to column...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/27/2019
Entry Details
US Patent

LigandPNGBDBM361931(9-ethyl-8-(2-methylpyrimidin-5- yl)-N-[(1S)-1-(1,4...)
Affinity DataIC50: 21nMAssay Description:Compounds are serially diluted (3-fold in 100% DMSO) across a 384-well polypropylene source plated from column 3 to column 12 and column 13 to column...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/27/2019
Entry Details
US Patent

LigandPNGBDBM361974(N-[(1S)-1-{[cis-4-acetyl-3,5- dimethylpiperazin-1-...)
Affinity DataIC50: 21nMAssay Description:Compounds are serially diluted (3-fold in 100% DMSO) across a 384-well polypropylene source plated from column 3 to column 12 and column 13 to column...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/27/2019
Entry Details
US Patent

LigandPNGBDBM361934(N-{(1S)-1-[((S and R)-2- cyclopropylmorpholin-4- y...)
Affinity DataIC50: 22nMAssay Description:Compounds are serially diluted (3-fold in 100% DMSO) across a 384-well polypropylene source plated from column 3 to column 12 and column 13 to column...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/27/2019
Entry Details
US Patent

LigandPNGBDBM361915(9-ethyl-N-{(1S)-1-[(4- methoxyazepan-1- yl)carbony...)
Affinity DataIC50: 23nMAssay Description:Compounds are serially diluted (3-fold in 100% DMSO) across a 384-well polypropylene source plated from column 3 to column 12 and column 13 to column...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/27/2019
Entry Details
US Patent

LigandPNGBDBM361963(N-[(1-{[(cis)-2,6- dimethylmorpholin-4- yl]carbony...)
Affinity DataIC50: 24nMAssay Description:Compounds are serially diluted (3-fold in 100% DMSO) across a 384-well polypropylene source plated from column 3 to column 12 and column 13 to column...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/27/2019
Entry Details
US Patent

LigandPNGBDBM361905((R or S)-8-(1-ethyl-5-methyl-1H- pyrazol-4-yl)-9-m...)
Affinity DataIC50: 24nMAssay Description:Compounds are serially diluted (3-fold in 100% DMSO) across a 384-well polypropylene source plated from column 3 to column 12 and column 13 to column...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/27/2019
Entry Details
US Patent

LigandPNGBDBM361977((S or R)-4-[(2S)-2-{[9-ethyl-8- (2-methylpyrimidin...)
Affinity DataIC50: 26nMAssay Description:Compounds are serially diluted (3-fold in 100% DMSO) across a 384-well polypropylene source plated from column 3 to column 12 and column 13 to column...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/27/2019
Entry Details
US Patent

LigandPNGBDBM361919(1-[(2S)-2-{[9-ethyl-8-(2- methylpyrimidin-5-yl)-9H...)
Affinity DataIC50: 26nMAssay Description:Compounds are serially diluted (3-fold in 100% DMSO) across a 384-well polypropylene source plated from column 3 to column 12 and column 13 to column...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/27/2019
Entry Details
US Patent

LigandPNGBDBM361951(N-[(1S)-1-{[(cis)-2,6- dimethylmorpholin-4- yl]car...)
Affinity DataIC50: 26nMAssay Description:Compounds are serially diluted (3-fold in 100% DMSO) across a 384-well polypropylene source plated from column 3 to column 12 and column 13 to column...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/27/2019
Entry Details
US Patent

LigandPNGBDBM361901((R and S)-N-[1-(azetidin-1- ylcarbonyl)propyl]-8-(...)
Affinity DataIC50: 26nMAssay Description:Compounds are serially diluted (3-fold in 100% DMSO) across a 384-well polypropylene source plated from column 3 to column 12 and column 13 to column...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/27/2019
Entry Details
US Patent

LigandPNGBDBM361930(9-ethyl-8-(2-methylpyrimidin-5- yl)-N-{(1S)-1-[((S...)
Affinity DataIC50: 27nMAssay Description:Compounds are serially diluted (3-fold in 100% DMSO) across a 384-well polypropylene source plated from column 3 to column 12 and column 13 to column...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/27/2019
Entry Details
US Patent

LigandPNGBDBM361952(N-[(1S)-2-[(cis)-2,6- dimethylmorpholin-4-yl]-1- (...)
Affinity DataIC50: 27nMAssay Description:Compounds are serially diluted (3-fold in 100% DMSO) across a 384-well polypropylene source plated from column 3 to column 12 and column 13 to column...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/27/2019
Entry Details
US Patent

LigandPNGBDBM361966(9-ethyl-N-[(2R)-2-methyl-3-oxo- 3-pyrrolidin-1-ylp...)
Affinity DataIC50: 29nMAssay Description:Compounds are serially diluted (3-fold in 100% DMSO) across a 384-well polypropylene source plated from column 3 to column 12 and column 13 to column...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/27/2019
Entry Details
US Patent

LigandPNGBDBM361973((S or R)-3-cyclopropyl-1-(2- {[9-ethyl-8-(2- methy...)
Affinity DataIC50: 30nMAssay Description:Compounds are serially diluted (3-fold in 100% DMSO) across a 384-well polypropylene source plated from column 3 to column 12 and column 13 to column...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/27/2019
Entry Details
US Patent

Displayed 1 to 50 (of 83 total ) | Next | Last >>
Jump to: